HEPA

Hepion Pharmaceuticals
HEPA

Overview Fund Activity
Delisted

HEPA was delisted on the 12th of May, 2025.

Back to rankings

3 hedge funds and large institutions have $7.45M invested in Hepion Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EI
EAM Investors
California
+$3.11M
2
TCIM
TIAA CREF Investment Management
New York
+$2.08M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$708K
2
BFA
BlackRock Fund Advisors
California
-$315K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$131K
4
EVC
Eidelman Virant Capital
Missouri
-$76K
5
PFS
Prospera Financial Services
Texas
-$69K
Name Holding Trade Value Shares
Change 		Shares
Change %
CS
26
Credit Suisse
Switzerland
– -$61K – –
EVC
27
Eidelman Virant Capital
Missouri
– -$76K – –
CC
28
Callan Capital
California
– -$52K – –
CAL
29
Capital Advisors Ltd
Ohio
– -$1K – –
1
2